Jeffrey T. Ha
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Sex disparities in receiving evidence-based medications in patients with CKD.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: June 19, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial.
Journal: American journal of nephrology
Published: December 09, 2025
Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset.
Journal: Diabetes, obesity & metabolism
Published: October 28, 2025
Six-Weekly Versus Monthly Haemodialysis Blood Testing in an Australian Tertiary Kidney Service: A Quality, Safety, Green Nephrology Initiative and Cost-Saving Analysis.
Journal: Nephrology (Carlton, Vic.)
Published: June 09, 2025
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset.
Journal: Kidney360
Published: May 27, 2025
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality: A Retrospective Observational Study Based on National General Practice Dataset.
Journal: Kidney360
Published: May 27, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset.
Journal: Diabetes, obesity & metabolism
Published: April 29, 2025
Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level Pooled Analysis from the CANVAS Program and CREDENCE Trial.
Journal: Journal of cardiac failure
Published: January 16, 2025
Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation: A Binational Population-Based Study.
Journal: Kidney360
Published: December 02, 2024
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease.
Journal: NEJM evidence
Published: August 26, 2024
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada.
Journal: Kidney medicine
Published: July 26, 2023
Last Updated: 09/26/2026